MW-150 hydrochloride is primarily utilized in the field of neuroscience research due to its role as a selective inhibitor of p38α MAPK. It is particularly effective in studying the mechanisms of certain neurological disorders, as it targets specific pathways involved in cognitive functions, memory, and neuroinflammation. Researchers employ this compound to explore potential therapeutic interventions for conditions like Alzheimer's disease, where modulation of these pathways could offer significant benefits by reducing neuroinflammation and protecting synaptic function. Additionally, MW-150 hydrochloride is used in preclinical studies to understand the impact of its inhibition on synaptic plasticity and neuronal communication, providing valuable insights into brain function and potential treatment strategies. Its application extends to pharmacological studies aimed at developing novel drugs for neurodegenerative diseases.